{
 "id": "multiple-myeloma",
 "name": "Multiple Myeloma",
 "aliases": [
  "Multiple myeloma",
  "Myeloma"
 ],
 "acronyms": [],
 "bodySystem": "cancer",
 "parent": null,
 "children": [],
 "edition": "2026-11",
 "merkleRoot": "006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6",
 "builtFrom": "program.status and program.eligibility facts, grouped by the condition registry",
 "counts": {
  "open": 1,
  "limited": 0,
  "waitlist": 0,
  "closed": 5
 },
 "funds": [
  {
   "fund": "Multiple Myeloma - Medicare Access",
   "organization": "HealthWell Foundation",
   "status": "open",
   "dateOnPage": null,
   "awardLevelUsd": null,
   "insuranceTypes": null,
   "pageSays": "The page lists the fund as Open.",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  },
  {
   "fund": "Myeloma",
   "organization": "Blood Cancer United (formerly the Leukemia and Lymphoma Society)",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": 10000,
   "insuranceTypes": [
    "Medicaid",
    "Medicare",
    "TRICARE"
   ],
   "pageSays": "The page lists the fund as Soliciting Funding, which its own text defines as at maximum capacity and not enrolling new or renewal patients; no waitlist is kept.",
   "readOn": "2026-11-08",
   "source": "https://bloodcancerunited.org/financial-assistance/co-pay-assistance-program"
  },
  {
   "fund": "Multiple Myeloma",
   "organization": "CancerCare",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": null,
   "insuranceTypes": null,
   "pageSays": "The page marks the fund as not currently open for new enrollments (the fund row's own data-statuses attribute reads closed).",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "fund": "Multiple Myeloma",
   "organization": "Good Days",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": null,
   "insuranceTypes": null,
   "pageSays": "The page marks the fund as not currently open for new enrollments (the fund's list item on the page carries the class closed).",
   "readOn": "2026-11-08",
   "source": "https://mygooddays.org/patients/diseases-covered/"
  },
  {
   "fund": "Multiple myeloma",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": 10000,
   "insuranceTypes": [
    "Medicaid",
    "Medicare",
    "TRICARE"
   ],
   "pageSays": "The page lists the fund as Closed.",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  },
  {
   "fund": "Multiple myeloma health equity",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": 10000,
   "insuranceTypes": [
    "Medicaid",
    "Medicare",
    "TRICARE"
   ],
   "pageSays": "The page lists the fund as Closed.",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  }
 ],
 "drugsWhoseLabelNamesThisCondition": [
  {
   "ingredient": "POMALIDOMIDE",
   "pages": [
    {
     "brand": "Pomalyst",
     "url": "https://omnirx.org/negotiated-drugs/pomalyst"
    }
   ],
   "labelSentence": "... in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of ...",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%220169dbda-53df-4cd9-b989-ff7544f1bdf5%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "BMS Access Support",
     "url": "https://omnirx.org/assistance/bms-access-support-eliquis",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "Bristol Myers Squibb Patient Assistance Foundation",
     "url": "https://www.bmspaf.org/#/medicines",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": "additional REMS requirements",
     "listKind": "Medicines available through the Foundation",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": {
    "usd30DaySupply": 8650,
    "effective": "2027-01-01",
    "source": "https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/selected-drugs-negotiated-prices"
   }
  },
  {
   "ingredient": "Lenalidomide",
   "pages": [
    {
     "brand": "Revlimid",
     "url": "https://omnirx.org/medicines/revlimid"
    }
   ],
   "labelSentence": "Multiple myeloma (MM), in combination with dexamethasone ( 1.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%2251bfdd53-8fd9-4f86-bebe-75de29e6379d%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "BMS Access Support",
     "url": "https://omnirx.org/assistance/bms-access-support-eliquis",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "Cancer Drug Assistance (Multiple Programs)",
     "url": "https://omnirx.org/assistance/cancer-drug-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "Bristol Myers Squibb Patient Assistance Foundation",
     "url": "https://www.bmspaf.org/#/medicines",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": "additional REMS requirements",
     "listKind": "Medicines available through the Foundation",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Denosumab",
   "pages": [
    {
     "brand": "Prolia",
     "url": "https://omnirx.org/medicines/prolia"
    }
   ],
   "labelSentence": "Multiple Myeloma and Bone Metastasis from Solid Tumors Bomyntra is indicated for the prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from ...",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%2249d25732-e05d-47e4-98cb-67df04796d4b%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Ixazomib Citrate",
   "pages": [
    {
     "brand": "Ninlaro",
     "url": "https://omnirx.org/medicines/ninlaro"
    }
   ],
   "labelSentence": "NINLARO ® is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22038f2461-834b-4488-9ebd-863c83eef5a7%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Selinexor",
   "pages": [
    {
     "brand": "Xpovio",
     "url": "https://omnirx.org/medicines/xpovio"
    }
   ],
   "labelSentence": "In combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy ( 1.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22f6dd2682-75a6-4863-90a8-a3197f6f78a8%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": null
  }
 ],
 "fundsForRelatedCosts": [
  {
   "fund": "American Cancer Society Cancer Care Continuity Fund",
   "organization": "Patient Advocate Foundation",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.patientadvocate.org/connect-with-services/financial-aid-funds/"
  },
  {
   "need": "testing",
   "fund": "Cancer genetic and genomic testing",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "open",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  },
  {
   "need": "home care",
   "fund": "Cancer Home Care Services",
   "organization": "HealthWell Foundation",
   "status": "open",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  },
  {
   "need": "behavioral health",
   "fund": "Cancer-Related Behavioral Health",
   "organization": "HealthWell Foundation",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  },
  {
   "need": "pain management",
   "fund": "Cancer-Related Pain Management",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "caregiver support",
   "fund": "CancerCare CAR-T Caregiver Assistance Fund",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "caregiver support",
   "fund": "CancerCare Caregiver Financial Assistance Fund(s)",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "clinical trial costs",
   "fund": "CancerCare Clinical Trial Financial Assistance Fund",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "transportation",
   "fund": "CancerCare Gets You There - Transportation Assistance Fund(s)",
   "organization": "CancerCare",
   "status": "closed",
   "readOn": "2026-11-08",
   "source": "https://www.cancercare.org/copayfoundation"
  },
  {
   "need": "behavioral health",
   "fund": "Oncology Caregiver Behavioral Health Fund (Accepting phone applications only)",
   "organization": "HealthWell Foundation",
   "status": "open",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  }
 ],
 "note": "Each status is what the fund page said on readOn. It is not an eligibility determination. We hold only the organizations we read; no fund here does not mean no fund exists.",
 "licence": "CC BY 4.0 for the OmniRx compilation"
}